[ad_1]
Life-saving drug trials will get the green light more quickly under plans to take advantage of Brexit by cutting red tape.
Steve Barclay, the Health Secretary, will on Sunday announce a new fast-track process halving the time it takes for some research to get under way.
Regulators have cleared a backlog of more than 2,000 applications, which built up after a surge of interest in research in the aftermath of the pandemic.
Writing jointly with June Raine, the head of the Medicines and Healthcare products Regulatory Agency (MHRA), Mr Barclay pledged to streamline research processes further as part of the biggest reform of clinical trials for more than 20 years.
The changes have come about because regulators have more freedom to design their own processes, including identifying trials that can be authorised more quickly.
Although applications should be assessed within 30 days, the average wait hit four months earlier this year following a surge of applications. In an average year, the MHRA normally approves around 750 new trials per year. Since July, it has approved 2,200, wiping out a backlog of almost 1,000.
[ad_2]
Source link